{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T20:38:03Z","timestamp":1778791083275,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.mehy.2011.11.023","type":"journal-article","created":{"date-parts":[[2011,12,23]],"date-time":"2011-12-23T18:09:24Z","timestamp":1324663764000},"page":"385-388","source":"Crossref","is-referenced-by-count":6,"title":["Concurrent inhibition of TGF-\u03b2 and mitogen driven signaling cascades in Dupuytren\u2019s disease \u2013 Non-surgical treatment strategies from a signaling point of view"],"prefix":"10.1016","volume":"78","author":[{"given":"C.","family":"Krause","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Kloen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2011.11.023_b0005","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jhsa.2011.03.002","article-title":"The treatment of Dupuytren disease","volume":"36","author":"Desai","year":"2011","journal-title":"J Hand Surg Am"},{"key":"10.1016\/j.mehy.2011.11.023_b0010","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nrrheum.2010.180","article-title":"Scientific understanding and clinical management of Dupuytren disease","volume":"6","author":"Shih","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.mehy.2011.11.023_b0015","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","article-title":"The myofibroblast: one function, multiple origins","volume":"170","author":"Hinz","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.mehy.2011.11.023_b0020","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrm809","article-title":"Myofibroblasts and mechano-regulation of connective tissue remodelling","volume":"3","author":"Tomasek","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.mehy.2011.11.023_b0025","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1054\/bjps.1999.3187","article-title":"New insights in the development of Dupuytren\u2019s contracture: a review","volume":"52","author":"Kloen","year":"1999","journal-title":"Br J Plast Surg"},{"key":"10.1016\/j.mehy.2011.11.023_b0030","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1101029","article-title":"Wnt signaling and Dupuytren\u2019s disease","volume":"365","author":"Dolmans","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2011.11.023_b0035","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s11999-008-0590-z","article-title":"\u03b2-Catenin overexpression in Dupuytren\u2019s disease is unrelated to disease recurrence","volume":"467","author":"Degreef","year":"2009","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.mehy.2011.11.023_b0040","first-page":"383","article-title":"Molecular mechanisms and treatment strategies for Dupuytren\u2019s disease","volume":"6","author":"O\u2019Gorman","year":"2010","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.mehy.2011.11.023_b0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-5751-5-13","article-title":"Wnt expression is not correlated with beta-catenin dysregulation in Dupuytren\u2019s disease","volume":"5","author":"O\u2019Gorman","year":"2006","journal-title":"J Negat Results Biomed"},{"key":"10.1016\/j.mehy.2011.11.023_b0050","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJMoa0810866","article-title":"Injectable collagenase clostridium histolyticum for Dupuytren\u2019s contracture","volume":"361","author":"Hurst","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2011.11.023_b0055","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.mehy.2009.08.011","article-title":"Antifibrotic medication using a combination of N-acetyl-l-cysteine (NAC) and ACE inhibitors can prevent the recurrence of Dupuytren\u2019s disease","volume":"73","author":"Knobloch","year":"2009","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2011.11.023_b0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1755-1536-4-14","article-title":"Elevated transforming growth factor \u03b2 and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren\u2019s disease fibroblasts","volume":"4","author":"Krause","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.mehy.2011.11.023_b0065","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/37284","article-title":"TGF-\u03b2 signalling from cell membrane to nucleus through SMAD proteins","volume":"390","author":"Heldin","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2011.11.023_b0070","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/nrm2297","article-title":"TGF\u03b2-SMAD signal transduction: molecular specificity and functional flexibility","volume":"8","author":"Schmierer","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.mehy.2011.11.023_b0075","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbadis.2009.12.009","article-title":"Pathological roles of MAPK signaling pathways in human diseases","volume":"1802","author":"Kim","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.mehy.2011.11.023_b0080","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jhsb.2005.06.008","article-title":"Epidermal growth factor receptor (EGF-R) in Dupuytren\u2019s disease","volume":"30","author":"Augoff","year":"2005","journal-title":"J Hand Surg Br"},{"key":"10.1016\/j.mehy.2011.11.023_b0085","first-page":"661","article-title":"Basic fibroblast growth factor in Dupuytren\u2019s contracture","volume":"141","author":"Gonzalez","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1016\/j.mehy.2011.11.023_b0090","doi-asserted-by":"crossref","first-page":"L43","DOI":"10.1152\/ajplung.00096.2004","article-title":"FGF-18 is upregulated in the postnatal rat lung and enhances elastogenesis in myofibroblasts","volume":"288","author":"Chailley-Heu","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.mehy.2011.11.023_b0095","doi-asserted-by":"crossref","first-page":"8374","DOI":"10.1073\/pnas.82.24.8374","article-title":"Epidermal growth factor regulates the expression of its own receptor","volume":"82","author":"Clark","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2011.11.023_b0100","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1177\/002215540004800610","article-title":"Expression of epidermal growth factor and its receptor in cirrhotic liver disease","volume":"48","author":"Komuves","year":"2000","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.mehy.2011.11.023_b0105","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1038\/sj.emboj.7601818","article-title":"TGF-\u03b2 activates Erk MAP kinase signalling through direct phosphorylation of ShcA","volume":"26","author":"Lee","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/j.mehy.2011.11.023_b0110","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1523-1755.2001.059002579.x","article-title":"TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2)","volume":"59","author":"Strutz","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.mehy.2011.11.023_b0115","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.cell.2009.09.035","article-title":"Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways","volume":"139","author":"Alarcon","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2011.11.023_b0120","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1164\/rccm.200405-612OC","article-title":"Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor","volume":"171","author":"Bonniaud","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mehy.2011.11.023_b0125","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.ki.5002717","article-title":"Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis","volume":"73","author":"Petersen","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.mehy.2011.11.023_b0130","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2249.2010.04094.x","article-title":"Inhibition of transforming growth factor-\u03b2 signaling attenuates interleukin (IL)-18 plus IL-2-induced interstitial lung disease in mice","volume":"160","author":"Segawa","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.mehy.2011.11.023_b0135","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/SHK.0b013e3181aef736","article-title":"Biphasic effects of selective inhibition of transforming growth factor beta1 activin receptor-like kinase on LPS-induced lung injury","volume":"33","author":"Wei","year":"2010","journal-title":"Shock"},{"key":"10.1016\/j.mehy.2011.11.023_b0145","doi-asserted-by":"crossref","unstructured":"Krause C, Krause C, de Vink E. Action-based analysis of discrete degulatory networks with short-term stimuli. In:CMSB\u201910: Proc. 8th conference on computational methods in systems biology. New York, NY, USA; 2010. p. 66\u201375. doi:10.1145\/1839764.1839773.","DOI":"10.1145\/1839764.1839773"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711006049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987711006049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T09:17:15Z","timestamp":1561108635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987711006049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0306987711006049"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2011.11.023","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}